{
  "docId": "019de075-3cec-7700-94db-076a5ce30d84",
  "docSlug": "8c2d629a90974743be7d15f16a23e50f",
  "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 44,
  "pageCount": 56,
  "prevPage": 43,
  "nextPage": 45,
  "slideType": "solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a Venn diagram to illustrate target overlap and a tree diagram to show potential combination therapy paths.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/44",
  "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
  "deckJsonHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json",
  "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-44",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.3,
        "x": 0.65,
        "y": 0.35
      },
      "kind": "diagram",
      "text": "Precision immunology tree diagram showing monotherapies and combinations",
      "attrs": null,
      "subkind": "hub-spoke",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3ce63656-a50b-4090-9b90-61ce142406bd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.05,
        "y": 0.4
      },
      "kind": "diagram",
      "text": "Circular process diagram showing IBD patient treatment cycling",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2ef53aff-f131-4cc7-b92a-f03b18eae9fc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.25,
        "x": 0.35,
        "y": 0.35
      },
      "kind": "diagram",
      "text": "Venn diagram showing overlap of TL1A, IL-23, and alpha4beta7 targets",
      "attrs": null,
      "subkind": "venn",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b503d0fc-9072-4ed0-afbf-19e11e9d7eaa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.65,
        "x": 0.29,
        "y": 0.18
      },
      "kind": "title",
      "text": "We believe the future of IBD includes combination therapies and precision approaches to break the therapeutic ceiling",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0be3d09a-56ec-4b87-8f9e-88c5a00dbb05",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.02,
        "y": 0.04
      },
      "kind": "title",
      "text": "We aim to develop companion diagnostics to augment our therapeutic combinations and monotherapies",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "92773657-d053-423d-a889-e590acce7e66",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "84476625-8ef6-4b4d-88dd-eb7791b6e217",
      "evidence": "The slide seems to be targeted towards investors or stakeholders in the pharmaceutical industry, indicating a specific audience definition.",
      "confidence": 0.7
    },
    {
      "name": "Big Idea Formula",
      "slug": "big-idea-formula",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "16bfd72d-eff5-45ce-b226-f419fe10c2c6",
      "evidence": "The slide presents a clear and concise big idea: 'the future of IBD includes combination therapies and precision approaches to break the therapeutic ceiling'.",
      "confidence": 0.7
    },
    {
      "name": "SCQA Framework",
      "slug": "scqa-framework",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "c9f21eef-0aa7-4992-a83f-fe583d362db6",
      "evidence": "The slide follows a general SCQA ( Situation, Complication, Question, Answer) framework.",
      "confidence": 0.5
    }
  ],
  "frameworks": [
    {
      "name": "venn",
      "slug": null,
      "matchId": "cf470829-c85e-4007-8bed-682dfc81df39",
      "evidence": "Venn diagram used to show target overlap",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 44,
      "from": 31,
      "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence",
      "beatSlug": "evidence",
      "evidence": "The document provides evidence to support the company's solution",
      "position": 4,
      "confidence": 0.9,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}